Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-08

Clinical Trial Update: Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining short-course radiotherapy followed by CAPOX chemotherapy and Ivonescimab for locally advanced rectal cancer; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Ivonescimab (AK112/SMT112)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING